Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma

Background: Hepatocellular carcinoma (HCC) is a highly aggressive malignant disease, and numerous studies have demonstrated that an inflammatory environment can induce normal cells to transform into cancerous.Methods: We integrated genomic data to comprehensively assess the association between pyrop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zeng-Hong Wu, Zi-Wei Li, Dong-Liang Yang, Jia Liu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/29bfe4ed6b394449b1118446a27d0e99
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:29bfe4ed6b394449b1118446a27d0e99
record_format dspace
spelling oai:doaj.org-article:29bfe4ed6b394449b1118446a27d0e992021-11-15T05:10:54ZDevelopment and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma2296-634X10.3389/fcell.2021.713925https://doaj.org/article/29bfe4ed6b394449b1118446a27d0e992021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.713925/fullhttps://doaj.org/toc/2296-634XBackground: Hepatocellular carcinoma (HCC) is a highly aggressive malignant disease, and numerous studies have demonstrated that an inflammatory environment can induce normal cells to transform into cancerous.Methods: We integrated genomic data to comprehensively assess the association between pyroptosis and tumor microenvironment (TME) cell-infiltrating characteristics in HCC, as well as the potential molecular function and clinical significance of lncRNA.Results: The analysis of CNV alteration frequency displayed that CNV changes were common in 33 PRGs, and most were focused on copy number amplification. As a result of lasso regression analysis, nine differentially expressed lncRNAs (AL031985.3, NRAV, OSMR-AS1, AC073611.1, MKLN1-AS, AL137186.2, AL049840.4, MIR4435-2HG, and AL118511.1) were selected as independent prognosis factors of HCC patients. Patients at high risk have poorer survival than those in the low-risk group in training and testing cohorts. A low-risk score was significantly associated with an IC50 of chemotherapeutics such as bortezomib (p < 0.001), but a high-risk score was significantly linked to docetaxel (p < 0.001), implying that signature served as a prospective predictor for chemosensitivity.Conclusion: This work suggests pyroptosis-related lncRNAs features and their potential mechanisms on tumor microenvironment. The exploration may assist in identifying novel biomarkers and assist patients in predicting their prognosis, clinical diagnosis, and management.Zeng-Hong WuZi-Wei LiDong-Liang YangJia LiuFrontiers Media S.A.articlehepatocellular carcinomapyroptosislncRNAsTCGAprognosisBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic hepatocellular carcinoma
pyroptosis
lncRNAs
TCGA
prognosis
Biology (General)
QH301-705.5
spellingShingle hepatocellular carcinoma
pyroptosis
lncRNAs
TCGA
prognosis
Biology (General)
QH301-705.5
Zeng-Hong Wu
Zi-Wei Li
Dong-Liang Yang
Jia Liu
Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
description Background: Hepatocellular carcinoma (HCC) is a highly aggressive malignant disease, and numerous studies have demonstrated that an inflammatory environment can induce normal cells to transform into cancerous.Methods: We integrated genomic data to comprehensively assess the association between pyroptosis and tumor microenvironment (TME) cell-infiltrating characteristics in HCC, as well as the potential molecular function and clinical significance of lncRNA.Results: The analysis of CNV alteration frequency displayed that CNV changes were common in 33 PRGs, and most were focused on copy number amplification. As a result of lasso regression analysis, nine differentially expressed lncRNAs (AL031985.3, NRAV, OSMR-AS1, AC073611.1, MKLN1-AS, AL137186.2, AL049840.4, MIR4435-2HG, and AL118511.1) were selected as independent prognosis factors of HCC patients. Patients at high risk have poorer survival than those in the low-risk group in training and testing cohorts. A low-risk score was significantly associated with an IC50 of chemotherapeutics such as bortezomib (p < 0.001), but a high-risk score was significantly linked to docetaxel (p < 0.001), implying that signature served as a prospective predictor for chemosensitivity.Conclusion: This work suggests pyroptosis-related lncRNAs features and their potential mechanisms on tumor microenvironment. The exploration may assist in identifying novel biomarkers and assist patients in predicting their prognosis, clinical diagnosis, and management.
format article
author Zeng-Hong Wu
Zi-Wei Li
Dong-Liang Yang
Jia Liu
author_facet Zeng-Hong Wu
Zi-Wei Li
Dong-Liang Yang
Jia Liu
author_sort Zeng-Hong Wu
title Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
title_short Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
title_full Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
title_fullStr Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
title_full_unstemmed Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
title_sort development and validation of a pyroptosis-related long non-coding rna signature for hepatocellular carcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/29bfe4ed6b394449b1118446a27d0e99
work_keys_str_mv AT zenghongwu developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma
AT ziweili developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma
AT dongliangyang developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma
AT jialiu developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma
_version_ 1718428797240344576